Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2009 R21 RFA-CA-08-006 WIRTZ, DENIS JOHNS HOPKINS UNIVERSITY HIGH-THROUGHPUT INTRACELLULAR MICRORHEOLOGY: A NEW TOOL FOR CANCER RESEARCH Complete
2012 R33 RFA-CA-12-005 LIOTTA, LANCE ALLEN GEORGE MASON UNIVERSITY NANOTRAP TECHNOLOGY FOR ONE STEP PRESERVATION AND AMPLIFICATION OF CANCER BIOMARK Complete
2016 R21 RFA-CA-15-002 MATOUSCHEK, ANDREAS UNIVERSITY OF TEXAS, AUSTIN DEVELOPMENT OF PROTEASOME ADAPTORS TO CATALYTICALLY DEPLETE SPECIFIC PROTEINS FROM CELLS Complete
2000 R21 PAR-99-100 FORTINA, PAOLO M CHILDREN'S HOSPITAL OF PHILADELPHIA FOUR COLOR ARRAY BOUND SNP/MUTATION DETECTION IN CANCER Complete
2002 R33 PAR-01-106 SCHNITZER, JAN EUGENIUSZ SIDNEY KIMMEL CANCER CENTER TECHNOLOGY TO UNMASK ACCESSIBLE TUMOR VASCULAR TARGETS Complete
2005 R33 RFA-CA-05-002 SCHWARTZ, DAVID C. UNIVERSITY OF WISCONSIN MADISON SINGLE MOLECULE GENOME ANALYSIS OF OLIGODENDROGLIOMA Complete
2008 R21 RFA-CA-07-037 YANNELLI, JOHN R. UNIVERSITY OF KENTUCKY CRYOPREPARATION OF PBMC FOR IMMUNOTHERAPY AND IMMUNE ASSESSMENT STUDIES. Complete
2011 R21 RFA-CA-10-005 RAO, JIANGHONG STANFORD UNIVERSITY NANOTECHNOLOGY FOR MULTIPLEX DETECTION OF ENZYMES Complete
2015 R33 RFA-CA-14-004 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS VALIDATION AND ADVANCED DEVELOPMENT OF GLYCAN NODE ANALYSIS IN LUNG CANCER RESEARCH Complete
2018 R21 RFA-CA-17-012 SKARDAL, ALEKSANDER (contact); STROWD, ROY ERVIN WAKE FOREST UNIVERSITY HEALTH SCIENCES Predicting Tumor Heterogeneity Evolution After Therapy In Patient-Derived Ex Vivo Glioblastoma Organoids Complete
1999 R43 PAR-98-066 MONFORTE, JOSEPH A GENETRACE SYSTEMS, INC. EXPRESSION MONITORING OF MULTIPLEXED CANCER GENE SETS Complete
2001 R44 PAR-99-101 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM Complete
2004 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER Complete
2007 R43 RFA-CA-07-008 MEDGHALCHI, SUSAN FASGEN, INC. FATTY ACID SYNTHASE PHOSPHORYLATION AS A CANCER BIOMARKER Complete
2010 R33 RFA-CA-09-007 ROBINSON, JOSEPH PAUL PURDUE UNIVERSITY SPECIFIC DETECTION OF CERVICAL CANCERS USING CYTOMETRY-BASED MOLECULAR DIAGNOSTIC Complete
2014 R43 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY Complete
2021 R33 CA20-018 JIANG, NING JENNY UNIVERSITY OF PENNSYLVANIA A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells Complete
1999 R21 PAR-98-067 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES ULTRA-SENSITIVE APPROACH FOR MONITORING GENE PRODUCTION Complete
2001 R33 PAR-99-100 TUNG, CHING-HSUAN MASSACHUSETTS GENERAL HOSPITAL IN VIVO IMAGING OF MATRIX METALLOPROTEASE Complete
2003 R44 PAR-01-104 GOLOVLEV, VAL V SCI-TEC, INC. MAGNETICALLY READABLE MICROARRAY Complete
2007 R21 RFA-CA-07-002 KERR, WILLIAM GARROW H. LEE MOFFITT CANCER CTR & RES INST DEFINING THE MULTIPLE MYELOMA KINOME Complete
2009 R44 RFA-CA-07-010 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING Complete
2013 R33 RFA-CA-13-002 KUHN, PETER SCRIPPS RESEARCH INSTITUTE CLINICAL VALIDATION OF THE HD-CTC FLUID BIOPSY IN EARLY DETECTION OF LUNG CANCER. Complete
2017 R21 RFA-CA-16-001 WALTER, NILS G UNIVERSITY OF MICHIGAN AT ANN ARBOR Single-molecule counting of cancer biomarker miRNAs in human biofluids Complete
2000 R43 PAR-99-101 SERBEDZIJA, GEORGE N PHYLONIX PHARMACEUTICALS, INC. WHOLE ANIMAL APOPTOSIS ASSAY FOR CANCER DRUG SCREENING Complete
2002 R43 PAR-01-105 LATHAM, GARY J AMBION, INC. ENZYMATIC TOOLS FOR DEGRADING TISSUE AND PRESERVING RNA Complete
2006 R21 RFA-CA-06-004 JU, JINGFANG UNIVERSITY OF SOUTH ALABAMA NOVEL METHOD FOR ISOLATING ACTIVELY TRANSLATED MRNAS Complete
2009 R21 RFA-CA-08-006 KANDEL, EUGENE S ROSWELL PARK CANCER INSTITUTE CORP ARRAY-ASSISTED INSERTIONAL MUTAGENESIS FOR MOLECULAR ANALYSIS OF CANCER Complete
2013 R21 RFA-CA-12-002 LU, CHANG VIRGINIA POLYTECHNIC INST AND ST UNIV SENSITIVE AND INTEGRATED MICROFLUIDIC CHIP ASSAYS FOR STUDYING TRANSCRIPTIONAL RE Complete
2016 R21 RFA-CA-15-002 RECHT, MICHAEL PALO ALTO RESEARCH CENTER HIGH-THROUGHPUT SCREENING PLATFORM FOR CANCER DRUG DISCOVERY Complete
2000 R21 PAR-99-100 STANTON, MARTIN J BRANDEIS UNIVERSITY APTAMER BASED DETECTOR TO QUANTIFY MACROMOLECULES Complete
2002 R33 PAR-98-067 CHANCE, MARK R YESHIVA UNIVERSITY DYNAMICS OF MACROMOLECULAR INTERACTIONS Complete
2005 R33 RFA-CA-05-002 BAKER, JAMES R UNIVERSITY OF MICHIGAN AT ANN ARBOR PHOTONIC CRYSTAL FIBER PROBE FLUORESCENCE BIOSENSING Complete
2008 R21 RFA-CA-07-037 WEIER, HEINZ-ULRICH GUENTER UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB ACCELERATING CANCER RESEARCH WITH SINGLE CELL ARRAYS Complete
2011 R21 RFA-CA-10-005 LAWRENCE, DAVID A WADSWORTH CENTER HOLISTIC DIAGNOSTICS OF HOST DURING DEVELOPMENT OF CANCER Complete
2015 R33 RFA-CA-14-004 MANALIS, SCOTT R MASSACHUSETTS INSTITUTE OF TECHNOLOGY SINGLE CELL GROWTH ASSAY FOR RESIDUAL CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA Complete
2017 R33 RFA-CA-16-002 WALTER, MATTHEW J WASHINGTON UNIVERSITY TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES NCE
2017 R33 RFA-CA-16-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity NCE
2017 R21 RFA-CA-16-001 EASWARAN, HARIHARAN JOHNS HOPKINS UNIVERSITY High-efficiency microfluidic-assisted single-cell DNA methylome sequencing NCE
2017 R21 RFA-CA-16-001 MOHS, AARON M. UNIVERSITY OF NEBRASKA MEDICAL CENTER Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications NCE
2017 R21 RFA-CA-16-001 NAEGLE, KRISTEN M WASHINGTON UNIVERSITY A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINS NCE
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations NCE
2018 R21 RFA-CA-17-010 FIELDS, RYAN C WASHINGTON UNIVERSITY Advancing Cancer Biology, Diagnostics and Therapeutics Outside of the Patient: Creation of a Novel, Autologous, Ex Vivo, Vascularized Model of the Tumor Microenvironment NCE
2017 R21 RFA-CA-16-001 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Engineered regulation of tyrosine phosphatase activity in living cells NCE
2017 R21 RFA-CA-16-001 BROCK, AMY UNIVERSITY OF TEXAS, AUSTIN High resolution cell lineage tracking and isolation NCE
2019 R21 RFA-CA-18-002 HUANG, XIAOHUA UNIVERSITY OF CALIFORNIA, SAN DIEGO Technology for measuring telomere length of individual chromosomes of single cancer cells NCE
2018 R21 RFA-CA-17-010 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Optogenetic tools for the dissection of oncogenic signaling mediated by kinases NCE
2018 R21 RFA-CA-17-010 MEHTA, ANAND S MEDICAL UNIVERSITY OF SOUTH CAROLINA Glyco-typer: an antibody capture glycan imaging methodology NCE
2018 R21 RFA-CA-17-010 ROBLES, FRANCISCO E GEORGIA INSTITUTE OF TECHNOLOGY Stimulated Raman scattering spectroscopic optical coherence tomography (SRS-SOCT) for label-free molecular imaging of brain tumor pathology NCE
2018 R21 RFA-CA-17-010 SCHIBEL, ANNA ELECTRONIC BIOSCIENCES, INC. Microsatellite Sequencing to Enable Cancer Genotyping NCE

Pages